Andrew Coveler, MD
I wanted to work at an institution that provides patient-centered care and plentiful opportunities for people to take part in clinical trials with new and novel treatments. Fred Hutch has been at the forefront of using the immune system to fight cancer. Though there has been limited success so far bringing immune-based therapies to GI cancers, I am hopeful it will happen. In addition, I enjoy working with the next generation of physicians, and I am able to do that by being a part of Fred Hutch and its partner organizations.
My goal is to partner with you and your family so that you can take an active role in your care. I am an advocate for your choices so that you can confront the disease on your own terms. I strive to guide you through what’s unknown, sharing information about your disease, prognosis and treatment options. It is an honor to care for people with challenging diagnoses.
Specialty: Medical Oncology
As the director of the Pancreatic Cancer Specialty Clinic, I review almost all the records of patients coming to Fred Hutch with pancreas cancer. You are likely to see one of my colleagues, but we often start the evaluation before you walk in the door so that your first visit is useful to you.
I am a medical oncologist who treats people with cancers of the gastrointestinal (GI) system, which includes many organs, such as the stomach and liver. My research spans several GI cancers. As a member of the Phase I Program, I collaborate with colleagues to bring new and novel therapies to Fred Hutch and those who come here for care.
Dr. Coveler has received this peer-nominated award for his exceptional patient care multiple years in a row.
Stories and testimonials
Join our renowned experts from Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and the University of Washington for the 12th Annual Comprehensive Hematology and Oncology Review Course.
When John Nowoj was diagnosed with locally advanced pancreatic cancer in August 2019, he was told the cancer was inoperable. Nowoj, 57, began pursuing his only treatment option: chemotherapy to be followed by radiation, which could shrink but not eradicate the tumor. Then an unexpected development completely changed the outlook.
We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our Fred Hutch doctors conduct ongoing research to improve standards of patient care. Their work is evaluated by other doctors and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch provider has written.
Our providers are often asked to give their medical expertise for press and news publications. Read articles by or about this Fred Hutch provider.
SCCA's Andrew Coveler, MD, discussed how managing pancreatic cancer patient’s pain can help patients live longer and improve their quality of life.
SCCA's Andrew Coveler, MD, discussed the toxicity profile of NUC-3373 in metastatic colorectal cancer.
Your care team
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.